In comparison, the recently published longitudinally dynamic biomarkers of PD in blood, HNF4A and PTBP1, did not show significantly altered levels at this prodromal stage (n=9 control versus n=12 PARK4 individuals). Here, HNF4A is linked to Parkinson disease.